/PRNewswire/ -- OrthAlign, Inc., the leader in handheld orthopedic navigation, has secured FDA 510(k) clearance for the Lantern ASC system, an innovation that brings advanced precision to procedures at lower cost and reduced complexity compared to robotic alternatives. As ambulatory surgery centers continue expanding rapidly within orthopedics, Lantern ASC equips these facilities with a key edge by delivering excellent clinical results without large capital outlays or restrictive implant volume requirements often tied to robotic platforms.

Robotic solutions typically involve substantial initial spending, extended preparation periods, and challenging learning curves inside the operating room. Lantern ASC overcomes these hurdles completely. Tailored specifically for ASC settings, the system combines a reusable navigation device with a procedural Smart Pack Kit to provide precise, live guidance during total knee, partial knee, and gap balancing cases in both primary and revision surgeries. This compact, flexible, and ready-to-use platform integrates smoothly with current Lantern tools and works with most implant brands. Lantern ASC fulfills modern ASC demands as an Accurate, Simple, and Cost-effective solution.

"With total joint arthroplasty moving into ASC environments and patients requesting advanced options for knee or hip replacements, surgeons and facility leaders require a balanced approach that addresses both clinical needs and financial realities," said Eric Timko, CEO of OrthAlign. "Lantern ASC was developed to support every participant involved. Surgeons receive dependable accuracy, patients achieve desired results, and the organization gains technology that supports its financial goals. Unlike systems that strain budgets and slow operating room flow, Lantern ASC enhances efficiency, matches or improves upon manual procedure durations, and delivers accessible navigation suited to the full ASC setting."

"The range of orthopedic technologies has grown considerably, giving ASCs increased choices for incorporating advanced tools," said Michael Ast, MD, Chief Medical Innovation Officer and Director of ASC Strategy at Hospital for Special Surgery. "Lantern ASC distinguishes itself through design focused on the operational and economic conditions unique to ASCs. It supplies consistent advanced performance without the capital demands, implant limitations, or workflow issues associated with more infrastructure-heavy robots. Centers prioritizing speed, volume, and fiscal responsibility will find it an outstanding match."

With ASCs securing greater portions of total joint cases, the need for solutions that enhance both clinical performance and economic results continues to rise. OrthAlign's Lantern ASC builds on the foundation of more than 450,000 prior procedures. As the market emphasizes operational and financial discipline, OrthAlign stands ready to support its next half-million patients as the leading provider of accessible navigation technology.

About OrthAlign, Inc.

OrthAlign is a medical device company dedicated to practical, advanced technologies for orthopedic procedures. Focused on innovation and quality, OrthAlign equips surgeons with intuitive, affordable tools that enhance patient outcomes in joint replacement surgery.

Guided by the principle that exceptional healthcare should be available to everyone, the company works to extend empowering technologies across all care settings.

For details on OrthAlign, please visit www.orthalign.com.

Lantern is a registered trademark of OrthAlign, Inc.

SOURCE OrthAlign